Retinal and orbital venous occlusions treated with enoxaparin

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 4, 2008, Pages 421-426

  Steigerwalt Jr , Robert D ^a   Cesarone, M Rosaria ^b   Belcaro, Gianni ^b   Quercioli, Pierpaolo ^c   Lofoco, Giorgio ^c   Ciucci, Francesco ^c   Pascarella, Antonella ^c   Angelis, Mauro De ^c   Rapagnetta, Laura ^c   Nebbioso, Marcella ^d  

^a Vascular Research Center ^*  (Italy)

^b Department of Ophthalmology   (Italy)

^c Ophthalmic Hospital   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; PREDNISONE; TICLOPIDINE;

ADULT; AGED; ARGON LASER; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORBIT EDEMA; RETINA EDEMA; RETINA HEMORRHAGE; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; ORBIT; RETINAL VEIN OCCLUSION;

EID: 48349093814     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0108     Document Type: Article

References (21)

1. Clarkson, J.G. Central retinal vein occlusion. In: Ryan, S.J. ed. Retina, 3rd ed, Vol 2. St Louis, MO: Mosby, 2001:1368.
2. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch. Ophthalmol. 114:545-554, 1996.
3. Hayreh, S.S. Classification of central retinal vein occlusion. Ophthalmology 90:458-474, 1983.
4. Magargal, L.E., Kimmel, A.S., et al. Temporal branch retinal vein occlusion: A review. Ophthalmol. Surg. 17:240-246, 1986.
5. Magaral, L.E., Brown, G.C., Augsburger, J.J., et al. Neovascular glaucoma following central retinal vein occlusion. Ophthalmology 88:1095-1101, 1981.
6. Duff, I.F., Falls, H.F., and Linman, J.W. Anticoagulant therapy in occlusive vascular disease of the retina. AMA Arch. Ophthalmol. 46:601-617, 1951.
7. Larsson, S., and Nord, B. Some remarks on retinal vein thrombosis and its treatment with anticoagulants. Acta. Ophthalmol. 28:187-201, 1950.
8. Browning, D.J., and Fraser, C.M. Retinal vein occlusions in patients taking warfarin. Ophthalmology 111:1196-1200, 2004.
9. Ducos de Lahitte, G., Quintyn, J.C., Leparmentier, A., et al. Retinal vein occlusions in patients treated with anticoagulant and/or platelet aggregation inhibitors. Five case studies. J. Fr. Ophthalmol. 30:145-149, 2007.
10. Koizumi, H., Ferrara, D.C., Bruè, C., et al. Central retinal vein occlusion case-control study. Am. J. Ophthalmol. 144:858-863, 2007.
11. Mruthyunjaya, P., Wirostko, W.J., Chandrashekhar, R., et al. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina 26:285-291, 2006.
12. Lee, Y.H., Lee, J.Y., Kim, Y.S., et al. Successful anticoagulation for bilateral central retinal vein occlusions accompanied by cerebral venous thrombosis. Arch. Neurol. 64:609, 2007.
13. Atkinson, M.C., and Worthley, L.I. Acute venous thromboembolism. Crit. Care Resuse 2:290-303, 2000.
14. Gerotziafas, G.T., and Samama, M.M. Prophylaxis of venous thromboembolism in medical patients. [review] Curr. Opin. Pulm. Med. 10:356-365, 2004.
15. Fareed, J., Hoppensteadt, D., Walenga, J., et al. Pharmacodynamic and pharmacokinetic properties of enoxaparin. Clin. Pharmacokinet. 42:1043-1057, 2003.
16. Martel, N., Lee, J., and Wells, P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 106:2710-2715, 2005.
17. Rabena, M.D., Pieramici, D.J., Castellarin, A.A., et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27:419-425, 2007.
18. Priglinger, S.G., Wolf, A.H., Kreutzer, T.C., et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: Six-month results of a prospective trial. Retina 27:1004-1012, 2007.
19. Ferrar, D.A., Koizumi, H., and Spaide, R.F. Early bevacizumab treatment of central retinal vein occlusion. Am. J. Ophthalmol. 144:864-871, 2007.
20. Pe'er, J., Folberg, R., Itin, A., et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105:412-416, 1998.
21. Tolentino, M.J., McLeod, D.S., Taomoto, M., et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am. J. Ophthalmol. 133:373-385, 2002.